Medical test
Medical test with a member traction device
This case study shows how member traction can enlarge member size. The patients in this study are between 23-47 years old and they all showed permanent results and no complications! The average lengthening per week was 1.2 mm.
All of our medical tests
1. In troduction
Based on the evidence of human tissue response to stretching, a traction device for non-invasive male reproductive lengthening has been designed and tested.
Traction device
– Basic ring, fastened proximally around the root of the member, abutting on the symphysis.
– Two adjustable metal bars hinged to the ring, connecting it to the silicon-support, fastened around the corona glandis at the distal end of the member.
– By gradually increasing the tractive force on the two metal bars a stretching force is exerted on the corporae, which equals a tractive force of a 600-1500 g weight attached to the member.
2. Material andmethods
Number of Patients: | 10 Patients raging from 23-47 years. |
---|---|
Patient Selection | Inclusion: Normal erectile capacity and no male reproductive surgery Exclusion: Chronically diseases |
Traction Force | 0 - 2 weeks: 900 - 1000g
2 - 26 weeks: 1000 - 1200g |
Treatment Period | 12 hours daily 7 days a week 8 to 26 weeks |
Follow Up | Every 2 weeks |
3. Results and results in erection
4. Conclusions
Preliminary study
– All patients achieved male reproductive lengthening after traction
– Lengthening per week was 1,2 mm
– No complications
– Medical indications:
a) non-invasive: hypoplasic member, Peyronie’s
b) postoperative: hypospadias / epispadias, male reproductive lengthening procedures
1st International Interdisciplinary Symposium on Genitourinary Reconstructive Surgery in Congenital Malformations, Transsexuals, and Impotence Barcelona, Spain, April 6, 7, and 8, 1998
http://onlinelibrary.wiley.com/doi/10.1002/j.1939-4640.1998.tb02485.x/abstract
MaleEdge products are certified medical devices with safety and efficacy assessed under Medical Device Directive 93/42/EEC in Europe.